130 related articles for article (PubMed ID: 37639289)
1. Crouch S, Painter D, Barrans SL, et al. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network. Blood Adv. 2022;6(21):5716-5731.
Blood Adv; 2023 Sep; 7(17):4999. PubMed ID: 37639289
[No Abstract] [Full Text] [Related]
2. Molecular subclusters of follicular lymphoma: a report from the United Kingdom's Haematological Malignancy Research Network.
Crouch S; Painter D; Barrans SL; Roman E; Beer PA; Cooke SL; Glover P; Van Hoppe SJL; Webster N; Lacy SE; Ruiz C; Campbell PJ; Hodson DJ; Patmore R; Burton C; Smith A; Tooze RM
Blood Adv; 2022 Nov; 6(21):5716-5731. PubMed ID: 35363872
[TBL] [Abstract][Full Text] [Related]
3. A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population-Based Observational Data.
Wang HI; Roman E; Crouch S; Aas E; Burton C; Patmore R; Smith A
Value Health; 2018 Oct; 21(10):1176-1185. PubMed ID: 30314618
[TBL] [Abstract][Full Text] [Related]
4. Palliative care specialists' perceptions concerning referral of haematology patients to their services: findings from a qualitative study.
McCaughan D; Roman E; Smith AG; Garry AC; Johnson MJ; Patmore RD; Howard MR; Howell DA
BMC Palliat Care; 2018 Feb; 17(1):33. PubMed ID: 29466968
[TBL] [Abstract][Full Text] [Related]
5. JSH practical guidelines for hematological malignancies, 2018: II. Lymphoma-1. Follicular lymphoma (FL).
Izutsu K
Int J Hematol; 2019 Jul; 110(1):11-19. PubMed ID: 31172373
[No Abstract] [Full Text] [Related]
6. Haematological cancer: the translocation behind follicular lymphoma development.
Sarkozy C; Coiffier B
Nat Rev Clin Oncol; 2014 Aug; 11(8):444-5. PubMed ID: 24935014
[No Abstract] [Full Text] [Related]
7. Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies.
Hernández-Molina G; Kostov B; Brito-Zerón P; Vissink A; Mandl T; Hinrichs AC; Quartuccio L; Baldini C; Seror R; Szántó A; Isenberg D; Gerli R; Nordmark G; Rasmussen A; Solans-Laque R; Hofauer B; Sène D; Pasoto SG; Rischmueller M; Praprotnik S; Gheita TA; Danda D; Armağan B; Suzuki Y; Valim V; Devauchelle-Pensec V; Retamozo S; Kvarnstrom M; Sebastian A; Atzeni F; Giacomelli R; Carsons SE; Kwok SK; Nakamura H; Fernandes Moça Trevisani V; Flores-Chávez A; Mariette X; Ramos-Casals M;
Rheumatology (Oxford); 2022 Dec; 62(1):243-255. PubMed ID: 35385104
[TBL] [Abstract][Full Text] [Related]
8. Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts.
Roman E; Kane E; Howell D; Lamb M; Bagguley T; Crouch S; Painter D; Patmore R; Smith A
Int J Epidemiol; 2022 Jun; 51(3):e87-e94. PubMed ID: 35134983
[No Abstract] [Full Text] [Related]
9. Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study.
Murphy F; Kroll ME; Pirie K; Reeves G; Green J; Beral V
Br J Cancer; 2013 Jun; 108(11):2390-8. PubMed ID: 23640394
[TBL] [Abstract][Full Text] [Related]
10. [Hematology 2010].
Dreyling M; Subklewe M; Braess J; Spiekermann K
Dtsch Med Wochenschr; 2010 Jun; 135(25-26):1322-5. PubMed ID: 20556691
[No Abstract] [Full Text] [Related]
11. Fourth biannual report of the Cochrane Haematological Malignancies Group.
Kober T; Hülsewede H; Bohlius J; Engert A
J Natl Cancer Inst; 2006 Apr; 98(8):E1. PubMed ID: 16622111
[No Abstract] [Full Text] [Related]
12. Hematologic Malignancies Discovered on Investigation of Breast Abnormalities.
Alsadi A; Lin D; Alnajar H; Brickman A; Martyn C; Gattuso P
South Med J; 2017 Oct; 110(10):614-620. PubMed ID: 28973700
[TBL] [Abstract][Full Text] [Related]
13. Haematological cancer: rituximab maintenance improves the outcome of elderly patients with FL.
Jones B
Nat Rev Clin Oncol; 2013 Nov; 10(11):607. PubMed ID: 23999211
[No Abstract] [Full Text] [Related]
14. In situ follicular neoplasia/lymphoma: three illustrative cases exemplifying unique disease presentations.
Sakhadeo U; Mane A; Shet T
Indian J Pathol Microbiol; 2012; 55(2):218-21. PubMed ID: 22771648
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for follicular non-Hodgkin lymphoma.
Gajraj E; Chung H; Longson C; Stevens A
Lancet Oncol; 2008 Apr; 9(4):320-1. PubMed ID: 18405852
[No Abstract] [Full Text] [Related]
16. Risk of secondary haematological malignancies in patients with follicular lymphoma: an analysis of 1028 patients treated in the rituximab era.
Prusila REI; Sorigue M; Jauhiainen J; Mercadal S; Postila A; Salmi P; Tanhua T; Tikkanen S; Kakko S; Kuitunen H; Pollari M; Nystrand I; Kuusisto MEL; Vasala K; Jantunen E; Korkeila E; Karihtala P; Sancho JM; Turpeenniemi-Hujanen T; Kuittinen O
Br J Haematol; 2019 Nov; 187(3):364-371. PubMed ID: 31267514
[TBL] [Abstract][Full Text] [Related]
17. Reactive lymphoid hyperplasia with giant follicles associated with post-therapeutic state of hematological malignancies: a report of six cases.
Kojima M; Murayama K; Higuchi K; Matsumoto M; Tamaki Y; Masawa N
Leuk Lymphoma; 2006 Jul; 47(7):1404-6. PubMed ID: 16923578
[No Abstract] [Full Text] [Related]
18. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network.
Smith A; Howell D; Patmore R; Jack A; Roman E
Br J Cancer; 2011 Nov; 105(11):1684-92. PubMed ID: 22045184
[TBL] [Abstract][Full Text] [Related]
19. Haematological cancers.
Pearce L
Nurs Stand; 2016 Jul; 30(48):15. PubMed ID: 27461299
[TBL] [Abstract][Full Text] [Related]
20. Pathobiology and diagnosis of follicular lymphoma.
Klapper W
Semin Diagn Pathol; 2011 May; 28(2):146-60. PubMed ID: 21842700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
